Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic

Travis P. Baggett, Justine A. Scott, Mylinh H. Le, Fatma M. Shebl, Christopher Panella, Elena Losina, Clare Flanagan, Jessie M. Gaeta, View ORCID ProfileAnne Neilan, Emily P. Hyle, Amir Mohareb, Krishna P. Reddy, Mark J. Siedner, Guy Harling, Milton C. Weinstein, Andrea Ciaranello, View ORCID ProfilePooyan Kazemian, View ORCID ProfileKenneth A. Freedberg
doi: https://doi.org/10.1101/2020.08.07.20170498
Travis P. Baggett
1Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA
2Harvard Medical School, Boston, MA
3Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justine A. Scott
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mylinh H. Le
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fatma M. Shebl
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Panella
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Losina
8Department of Biostatistics, Boston University School of Public Health, Boston, MA
9Orthopedic and Arthritis Center for Outcomes Research (OrACORe), Department of Orthopedic Surgery, Brigham and Women’s Hospital, Boston, MA
10Policy and Innovation eValuation in Orthopedic Treatments (PIVOT) Center, Department of Orthopedic Surgery, Brigham and Women’s Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clare Flanagan
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessie M. Gaeta
3Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, MA
7Section of General Internal Medicine, Boston University School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Neilan
2Harvard Medical School, Boston, MA
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
11Division of General Academic Pediatrics, Department of Pediatrics, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne Neilan
Emily P. Hyle
2Harvard Medical School, Boston, MA
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
6Harvard University Center for AIDS Research, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amir Mohareb
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krishna P. Reddy
2Harvard Medical School, Boston, MA
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
12Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Siedner
2Harvard Medical School, Boston, MA
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
13Africa Health Research Institute, KwaZulu-Natal, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy Harling
14Department of Epidemiology and Harvard Center for Population & Development Studies, Harvard T.H. Chan School of Public Health, Boston, MA, USA
15Africa Health Research Institute, KwaZulu-Natal, South Africa
16Institute for Global Health, University College London, London, UK
17MRC/Wits Rural Public Health & Health Transitions Research Unit (Agincourt), University of Witwatersrand, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milton C. Weinstein
19Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Ciaranello
2Harvard Medical School, Boston, MA
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
6Harvard University Center for AIDS Research, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pooyan Kazemian
18Department of Operations, Weatherhead School of Management, Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pooyan Kazemian
Kenneth A. Freedberg
1Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA
2Harvard Medical School, Boston, MA
4Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA
5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
6Harvard University Center for AIDS Research, Boston, MA
19Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kenneth A. Freedberg
  • For correspondence: kfreedberg@mgh.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Importance Approximately 356,000 people stay in homeless shelters nightly in the US. They are at high risk for COVID-19.

Objective To assess clinical outcomes, costs, and cost-effectiveness of strategies for COVID-19 management among sheltered homeless adults.

Design We developed a dynamic microsimulation model of COVID-19 in sheltered homeless adults in Boston, Massachusetts. We used cohort characteristics and costs from Boston Health Care for the Homeless Program. Disease progression, transmission, and outcomes data were from published literature and national databases. We examined surging, growing, and slowing epidemics (effective reproduction numbers [Re] 2.6, 1.3, and 0.9). Costs were from a health care sector perspective; time horizon was 4 months, from April to August 2020.

Setting & Participants Simulated cohort of 2,258 adults residing in homeless shelters in Boston.

Interventions We assessed daily symptom screening with polymerase chain reaction (PCR) testing of screen-positives, universal PCR testing every 2 weeks, hospital-based COVID-19 care, alternate care sites [ACSs] for mild/moderate COVID-19, and temporary housing, each compared to no intervention.

Main Outcomes and Measures Cumulative infections and hospital-days, costs to the health care sector (US dollars), and cost-effectiveness, as incremental cost per case prevented of COVID-19.

Results We simulated a population of 2,258 sheltered homeless adults with mean age of 42.6 years. Compared to no intervention, daily symptom screening with ACSs for pending tests or confirmed COVID-19 and mild/moderate disease led to 37% fewer infections and 46% lower costs (Re=2.6), 75% fewer infections and 72% lower costs (Re=1.3), and 51% fewer infections and 51% lower costs (Re=0.9). Adding PCR testing every 2 weeks further decreased infections; incremental cost per case prevented was $1,000 (Re=2.6), $27,000 (Re=1.3), and $71,000 (Re=0.9). Temporary housing with PCR every 2 weeks was most effective but substantially more costly than other options. Results were sensitive to cost and sensitivity of PCR and ACS efficacy in preventing transmission.

Conclusions & Relevance In this modeling study of simulated adults living in homeless shelters, daily symptom screening and ACSs were associated with fewer COVID-19 infections and decreased costs compared with no intervention. In a modeled surging epidemic, adding universal PCR testing every 2 weeks was associated with further decrease in COVID-19 infections at modest incremental cost and should be considered during future surges.

Question What are the projected clinical outcomes and costs of strategies for reducing COVID-19 infections among people experiencing sheltered homelessness?

Findings In this microsimulation modeling study, daily symptom screening with polymerase chain reaction (PCR) testing of screen-positive individuals, paired with non-hospital care site management of people with mild to moderate COVID-19, substantially reduced infections and lowered costs over 4 months compared to no intervention, across a wide range of epidemic scenarios. In a surging epidemic, adding periodic universal PCR testing to symptom screening and non-hospital care site management improved clinical outcomes at modestly increased costs. Periodic universal PCR testing paired with temporary housing further reduced infections but at much higher cost.

Meaning Daily symptom screening with PCR testing of screen-positive individuals and use of alternate care sites for COVID-19 management among sheltered homeless people was associated with substantially reduced new cases and costs compared to other strategies.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the National Institute of Allergy and Infectious Disease [T32 AI007433 to AM] and the National Institute of Arthritis and Musculoskeletal and Skin Diseases [K24 AR057827 to EL] at the National Institutes of Health, and by the Royal Society and Wellcome Trust [210479/Z/18/Z to GH]. The funding sources had no role in the study design, data collection, data analysis, data interpretation, writing of the manuscript, or in the decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding sources.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Mass General Brigham Human Research Committee: The Human Research Committee is the Institutional Review Board (IRB) of Mass General Brigham on behalf of the BWH and MGH and approves all human-subject research conducted by a Mass General Brigham-affiliated investigator.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 20, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic
Travis P. Baggett, Justine A. Scott, Mylinh H. Le, Fatma M. Shebl, Christopher Panella, Elena Losina, Clare Flanagan, Jessie M. Gaeta, Anne Neilan, Emily P. Hyle, Amir Mohareb, Krishna P. Reddy, Mark J. Siedner, Guy Harling, Milton C. Weinstein, Andrea Ciaranello, Pooyan Kazemian, Kenneth A. Freedberg
medRxiv 2020.08.07.20170498; doi: https://doi.org/10.1101/2020.08.07.20170498
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic
Travis P. Baggett, Justine A. Scott, Mylinh H. Le, Fatma M. Shebl, Christopher Panella, Elena Losina, Clare Flanagan, Jessie M. Gaeta, Anne Neilan, Emily P. Hyle, Amir Mohareb, Krishna P. Reddy, Mark J. Siedner, Guy Harling, Milton C. Weinstein, Andrea Ciaranello, Pooyan Kazemian, Kenneth A. Freedberg
medRxiv 2020.08.07.20170498; doi: https://doi.org/10.1101/2020.08.07.20170498

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (943)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (419)
  • Epidemiology (8971)
  • Forensic Medicine (4)
  • Gastroenterology (418)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1323)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (212)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10772)
  • Intensive Care and Critical Care Medicine (571)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (221)
  • Neurology (1819)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1892)
  • Public and Global Health (4111)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (364)
  • Respiratory Medicine (548)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)